search
Back to results

Safety/Efficacy of Systane Free vs Refresh Liquigel

Primary Purpose

Dry Eye

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Systane Free Lubricant Eye Drops
Refresh Liquigel Lubricant Eye Drops
Sponsored by
Alcon Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dry Eye

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: >/= 3 corneal staining score using NEI scoring system. Need artificial tears at least some of the time. Other protocol-defined inclusion criteria may apply. Exclusion Criteria: History or evidence of ocular or intraocular surgery in either eye within the past six months. History of intolerance or hypersensitivity to any component of the study medication. Use of Restasis within 30 days of Visit 1. Participation in an investigational drug or device study within 30 days of entering this study. Other protocol-defined exclusion criteria may apply.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Systane

    Refresh

    Arm Description

    Outcomes

    Primary Outcome Measures

    Change in corneal staining at Day 28 from baseline (Day 0)

    Secondary Outcome Measures

    Full Information

    First Posted
    June 30, 2006
    Last Updated
    March 2, 2012
    Sponsor
    Alcon Research
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00348517
    Brief Title
    Safety/Efficacy of Systane Free vs Refresh Liquigel
    Official Title
    An Evaluation of the Safety and Efficacy of Systane Free FID 105783
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2012
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2006 (undefined)
    Primary Completion Date
    November 2006 (Actual)
    Study Completion Date
    November 2006 (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Alcon Research

    4. Oversight

    5. Study Description

    Brief Summary
    The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 when compared to Refresh Liquigel Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dry Eye

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    100 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Systane
    Arm Type
    Experimental
    Arm Title
    Refresh
    Arm Type
    Active Comparator
    Intervention Type
    Other
    Intervention Name(s)
    Systane Free Lubricant Eye Drops
    Intervention Description
    1-2 drops per eye four times per day for 42 days
    Intervention Type
    Other
    Intervention Name(s)
    Refresh Liquigel Lubricant Eye Drops
    Intervention Description
    1-2 drops per eye four times per day for 42 days
    Primary Outcome Measure Information:
    Title
    Change in corneal staining at Day 28 from baseline (Day 0)
    Time Frame
    Day 28

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: >/= 3 corneal staining score using NEI scoring system. Need artificial tears at least some of the time. Other protocol-defined inclusion criteria may apply. Exclusion Criteria: History or evidence of ocular or intraocular surgery in either eye within the past six months. History of intolerance or hypersensitivity to any component of the study medication. Use of Restasis within 30 days of Visit 1. Participation in an investigational drug or device study within 30 days of entering this study. Other protocol-defined exclusion criteria may apply.

    12. IPD Sharing Statement

    Learn more about this trial

    Safety/Efficacy of Systane Free vs Refresh Liquigel

    We'll reach out to this number within 24 hrs